GLP-1 drugs like Ozempic and Wegovy have garnered consumer attention for their ability to curb unhealthy food and beverage cravings, leading to weight loss, as large CPG companies and major retailers might be able to use the moment to refocus on providing...
The dietary supplement industry dodged another regulatory bullet when New York Gov. Kathy Hochul vetoed a bill that would have restricted the sales of some weight management and muscle building products in the state.
The US Food & Drug Administration has sent a letter to Amazon about the availability of drug-tainted sexual enhancement and weight loss products for sale on its platform, the majority of which were marketed as dietary supplements.
